Invoke Capital

Luminance Technologies Ltd., established in 2015 and headquartered in London, specializes in AI-driven document analysis software. It serves multinational and governmental organizations, offering a platform that accurately reviews, categorizes, and analyzes legal documents and contracts. The software identifies risk clauses, enables task allocation and progress tracking, and provides data visualization and anomaly detection. It also streamlines contract generation, negotiation, and post-execution analysis, helping businesses manage contract-related workflows efficiently.

Featurespace is a technology company that develops Adaptive Behavioral Analytics and automated deep behavioral networks to prevent fraud and financial crime. Its ARIC platform provides real-time risk scoring and anomaly detection to monitor customer data across transactions and channels, automatically identifying risk, blocking new fraud attacks, and distinguishing genuine activity. The ARIC Risk Hub operates in real time and is used by more than 30 major global financial institutions to protect customers and revenue, spanning multiple countries. The company serves financial institutions and other sectors, including responsible gambling and churn protection, by analyzing streams of customer data to detect anomalies and prevent loss while minimizing disruption to legitimate customers.

Featurespace is a technology company that develops Adaptive Behavioral Analytics and automated deep behavioral networks to prevent fraud and financial crime. Its ARIC platform provides real-time risk scoring and anomaly detection to monitor customer data across transactions and channels, automatically identifying risk, blocking new fraud attacks, and distinguishing genuine activity. The ARIC Risk Hub operates in real time and is used by more than 30 major global financial institutions to protect customers and revenue, spanning multiple countries. The company serves financial institutions and other sectors, including responsible gambling and churn protection, by analyzing streams of customer data to detect anomalies and prevent loss while minimizing disruption to legitimate customers.

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Luminance Technologies Ltd., established in 2015 and headquartered in London, specializes in AI-driven document analysis software. It serves multinational and governmental organizations, offering a platform that accurately reviews, categorizes, and analyzes legal documents and contracts. The software identifies risk clauses, enables task allocation and progress tracking, and provides data visualization and anomaly detection. It also streamlines contract generation, negotiation, and post-execution analysis, helping businesses manage contract-related workflows efficiently.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.

Neurence Limited is a technology company based in Cambridge, United Kingdom, specializing in self-learning artificial intelligence software solutions. Founded by a team of mathematicians and software engineers, Neurence has developed a cloud-based platform that acts as a central repository for information, enabling devices to perceive and interpret the world around them. This innovative platform allows devices to outsource their processing needs to Neurence's intelligent cloud, which leverages advanced mathematical and computational algorithms. By communicating sensory data to the cloud, devices can access accumulated knowledge and respond to various situations more effectively and efficiently. Neurence's system continuously learns from the experiences of connected devices, thereby optimizing their performance and reducing the need for significant on-board processing power. This capability allows for the development of lighter, faster, and more cost-effective devices, ultimately enhancing their functionality in understanding complex, unstructured environments.

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Darktrace Limited is a cybersecurity company that specializes in intelligence-led, behavioral cyber defense solutions. Founded in 2013 and headquartered in Cambridge, United Kingdom, the company employs self-learning artificial intelligence modeled on the human immune system to protect over 3,500 organizations from a wide range of cyber threats, including insider threats, industrial espionage, and malware. Darktrace's platform is designed for scalability and can be deployed as software, an appliance, or as a service. Key offerings include the Darktrace Cyber Intelligence Platform, which provides enterprise-wide security, and Darktrace Antigena, an autonomous response solution that neutralizes threats in real time. The company has a global presence with over 1,200 employees and 44 offices, serving clients in government, military, and private sectors. Darktrace also maintains a strategic partnership with Options Technology and generates significant revenue from the USA and Canada, along with operations in the UK, Europe, and other regions.